Rovin Capital Johnson & Johnson Transaction History

Rovin Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$160.2 - $179.79 $4,325 - $4,854	-27 Reduced 2.19%	1,204 $213,000
Q3 2022 Oct 25, 2022	BUY	$161.33 - $179.52 $967 - $1,077	6 Added 0.49%	1,231 $201,000
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $10,932 - $12,090	65 Added 5.6%	1,225 $217,000
Q1 2022 Jun 13, 2022	BUY	$158.14 - $179.59 $183,442 - $208,324	1,160 New	1,160 $206,000

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Rovin Capital , based on Form 13F filings with the SEC.

Stay updated on Rovin Capital with notifications on news.